Dimas Jimenez, MBA
Vice President, Corporate Controller
Dimas Jimenez. Mr. Jimenez has served as our Vice President and Corporate Controller since March 2020. From January 2018 to March 2020, Mr. Jimenez served as Chief Financial Officer, Consulting at DelNova, Inc., a biopharmaceutical company developing clinically validated molecules linked to advances in drug delivery. Mr. Jimenez also served as a consultant for various other life science start-ups where he advised them on business development and other aspects of corporate strategy. From December 2016 to April 2019, Mr. Jimenez served as Chief Financial Officer at StemoniX, Inc., a biotechnology company focused on stem cell technologies. From October 2015 to December 2016, Mr. Jimenez served as Chief Financial Officer at Orphagen Pharmaceuticals, Inc., a developer of small molecule drugs designed to treat certain orphan nuclear receptors. Mr. Jimenez earned a chartered financial analyst designation. Mr. Jimenez earned a B.S. in Economics and Government from Dartmouth University, and an M.B.A. in Finance and a Global Management certificate from Stanford University.